KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Change in Cash (2016 - 2025)

Historic Change in Cash for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $33.2 million.

  • Resmed's Change in Cash fell 6524.38% to $33.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $895.1 million, marking a year-over-year increase of 18717.79%. This contributed to the annual value of $971.1 million for FY2025, which is 917496.66% up from last year.
  • Latest data reveals that Resmed reported Change in Cash of $33.2 million as of Q4 2025, which was down 6524.38% from $174.4 million recorded in Q3 2025.
  • Over the past 5 years, Resmed's Change in Cash peaked at $410.8 million during Q1 2025, and registered a low of -$81.7 million during Q4 2021.
  • In the last 5 years, Resmed's Change in Cash had a median value of $17.5 million in 2022 and averaged $58.1 million.
  • As far as peak fluctuations go, Resmed's Change in Cash crashed by 44697.66% in 2023, and later skyrocketed by 6126119.73% in 2025.
  • Resmed's Change in Cash (Quarter) stood at -$81.7 million in 2021, then soared by 156.37% to $46.0 million in 2022, then crashed by 97.51% to $1.1 million in 2023, then soared by 8233.3% to $95.6 million in 2024, then tumbled by 65.24% to $33.2 million in 2025.
  • Its last three reported values are $33.2 million in Q4 2025, $174.4 million for Q3 2025, and $276.7 million during Q2 2025.